Close menu




October 15th, 2021 | 12:19 CEST

Bayer, Water Ways Technologies, K+S - Will there be enough food for everyone in the future?

  • agritech
Photo credits: pixabay.com

Humanity is growing and growing. In a few years, 10 billion people will populate the earth. The question then arises as to whether there will be enough food available in the future. One of the difficulties is climate change. If it gets hotter and hotter, less will grow, and if agricultural land becomes smaller, less food can be produced. To meet this challenge, yields on arable land must be increased. Fertilizers can help. Another critical factor will be water. Water is already scarce in some parts of the world, and drinking water is far from accessible to everyone everywhere. Today we analyze three companies that could play an important role in the future of food supply.

time to read: 4 minutes | Author: Armin Schulz
ISIN: BAYER AG NA O.N. | DE000BAY0017 , Water Ways Technologies | CA9411881043 , K+S AG NA O.N. | DE000KSAG888

Table of contents:


    Bayer - Sale of a division?

    Bayer has been well-positioned in the field of agrochemicals since the acquisition of Monsanto. Seeds and weed killers are essential for the future; however, the Group probably did not expect such a wave of lawsuits with the crop protection active ingredient glyphosate. This acquisition is still causing the Group problems today. Investors do not like the uncertainties resulting from the lawsuits. In addition, the purchase price for Monsanto was high, and Bayer even had to take on debt for the acquisition.

    Most recently, a glyphosate lawsuit was won, at least a small ray of hope for the beleaguered shareholders. There are increasing rumors that the Company wants to sell the pest control or weed killer division. A final decision has not yet been made. If there is a buyer, the price will ultimately have to be right. The Group intends to use the sales to reduce its debts. However, the Company did not want to comment further on the rumors.

    The chart of the share has brightened significantly in recent trading days. The downward trend was broken for the first time, and also a 123 formation was formed. As long as the support at EUR 45.76 is no longer undercut on a closing price basis, the chart picture remains bullish. The analysts at Bernstein are calling for a price target of EUR 76. Bayer's pharmaceuticals division is doing very well, and once the legal disputes at Monsanto have been settled, the stock certainly offers some potential. Until then, investors should be cautious. Pure chart traders could position themselves now.

    Water Ways Technologies - Irrigation systems worldwide

    Water Ways Technologies is headquartered in Canada but is originally from Israel and provides proprietary irrigation technology to its customers. The Company operates worldwide and has over 400 customers in over 40 countries. Wherever water is scarce or expensive, it pays to use an irrigation system. The plants are optimally supplied without water seeping away. The Company has set itself the goal of becoming the world leader in irrigation projects in the agricultural sector.

    The Company reported record figures for the first half of the year. Sales increased to CAD 12.1 million, and EBITDA was CAD 832,000. In mid-September, two new orders worth CAD 1.3 million were won. On September 29, the Company reported no less than three new orders in Mexico, China and Canada, with a total volume of CAD 570,000. According to Allied Market Research, the market for irrigation systems is expected to grow to USD 5.57 billion by 2027. In 2020, the volume was USD 1.44 billion.

    Water will gain in importance in the coming years, as on the one hand the earth's population is increasing and on the other hand it is currently getting warmer. The demand for irrigation technologies will therefore also increase. The share is 57% owned by insiders, which is a good sign. The market capitalization is currently CAD 24.1 million, with 2021 being a highly encouraging year for investors so far. At the beginning of the year, the share price was still at CAD 0.06 to rise to CAD 0.295 on August 30. From there, the share has consolidated to CAD 0.22 and is currently trading at CAD 0.24.

    K+S - Potash prices ensure turnaround

    Potash fertilizer prices have risen significantly recently. Following several natural disasters and periods of drought, demand for fertilizers has picked up. K+S benefits from this and, after a very long dry spell, can attract attention with sustained positive news. The share was also able to make gains in a weak market environment. As long as the price of potash remains at this level, the Company can generate large profits.

    Interested investors will find out how well things are currently going operationally on November 11, when the figures for the third quarter are to be presented. Deutsche Bank expects an EBITDA of EUR 121 million, representing year-on-year growth of a whopping 59%. Analysts expect earnings of EUR 2.03 per share. In recent weeks, more and more research houses have raised their expectations.

    Deutsche Bank has raised the price target to EUR 15 and left the share on Hold. Likewise, UBS has reacted and issued a target price of EUR 13.95. On October 11, the UBS target of EUR 14.52 was already exceeded. At this point, the share reached a new multi-year high and at the same time generated a new buy signal. If the estimates are achieved, the price-to-earnings ratio is below 7, and the price-to-book ratio is below 1 and can therefore be considered favorable.


    The areas around food production are booming. Bayer is still struggling with the Monsanto problem; otherwise, things are going well for the Group. Water Ways Technologies is growing strongly and was able to report record figures. K+S has achieved the turnaround thanks to the high potash price. The Company is now in a much better position than expected at the beginning of the year. As long as the raw material price does not drop significantly, the Company will continue to earn well.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Nico Popp on June 19th, 2026 | 07:35 CEST

    How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva

    • agritech
    • agrochemical
    • mustard
    • biologicals
    • fertilizer

    Created and published on behalf of MustGrow Biologics Corp.

    Extreme heat waves, increasingly degraded soils, and strict regulatory limits on synthetic chemical crop protection products—global agricultural markets are facing a critical period of adjustment. Once temperatures cross the critical threshold of 30 °C, most agricultural crops begin to suffer drastic yield losses, as sterile pollen and weakened cell walls cause irreparable damage to plant biology. According to the joint report by the Food and Agriculture Organization of the United Nations (FAO) and the World Meteorological Organization (WMO) titled "Extreme Heat and Agriculture," even individual heat waves can cause agricultural productivity to plummet by up to 50%. For most major crops, yield losses are already a threat at temperatures as low as 30 °C. The frequency, intensity, and duration of extreme heat events have increased significantly over the past 50 years. These ecological stressors are shifting growing conditions in both temperate and Mediterranean zones, forcing the entire agricultural value chain to rethink its approach.

    Read

    Commented by André Will-Laudien on June 16th, 2026 | 07:25 CEST

    USA–Iran: The Strait of Hormuz is Opening Up! A Sector Buy Signal for Bayer, MustGrow, BASF and K+S!

    • biologicals
    • agritech
    • mustard
    • fertilizer
    • chemicals

    Created and published on behalf of MustGrow Biologics Corp.

    Some things are ultimately not surprising. The "agreement" between the USA–Israel and Iran resembles shadow boxing. One step forward, one step back—that is how the movements at the trading desk appear. The stock markets are reacting accordingly. At the start of the week, optimism about a near-term end to the hostilities is once again dominating. Oil prices are correcting most sharply, down nearly 5%, with Brent now quoted at only USD 82.50 per barrel. This is a positive signal for chemical- and transport-oriented industries in the food sector, with BASF and Bayer showing corresponding strength. Large volumes of goods must be transported globally, and shipping routes carry significant operational importance. As part of efforts to ensure long-term food security, more and more ideas are emerging that could mitigate the international energy crisis. MustGrow focuses on natural ingredients rather than chemicals, while K+S represents a typical example of the "old economy" in this sector. For investors, multiple opportunities for returns are available!

    Read

    Commented by Armin Schulz on June 11th, 2026 | 06:45 CEST

    With Novo Nordisk, MustGrow Biologics, and Bayer: Positioning for Two Megatrends of the Decade

    • biologicals
    • mustard
    • agritech
    • Biotechnology
    • Biotech

    Created and published on behalf of MustGrow Biologics Corp.

    Two seemingly opposing crises—obesity and food scarcity—are creating major investment opportunities this year. While the obesity epidemic is placing increasing strain on healthcare systems, climate shocks and geopolitical conflicts are threatening global agricultural yields. The biotech sector is addressing both challenges through biological compounds for weight management and crop protection. Demand for effective obesity treatments and sustainable agricultural solutions is rising rapidly. Investors who position themselves early in the beneficiaries of this dual transformation may benefit from above-average returns. This is precisely where the three companies we are taking a closer look at today are positioned: Novo Nordisk, MustGrow Biologics, and Bayer.

    Read